Safety and Efficacy of Cellcept and Avonex as Combination Treatment in Multiple Sclerosis
Clinical trial NCT00324506 · COMPLETED
Trial details
- NCT number
- NCT00324506
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2009-06-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.